Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primary
Phase 2
- Conditions
- Cancer of unknown primary
- Registration Number
- JPRN-UMIN000001236
- Lead Sponsor
- ational Cancer Center Hospital, Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
a) Specific subgroups of CUP (female(adenocarcinoma, Ax LN metastases), female (adenocarcinoma, peritonitis carcinomatosa), squamous cell carcinoma of cervical LN metastases, etc.) b) history of any malignancies c) massive effusion (thorax or abdominal cavity) d) symptomatic brain metastases e) uncontrolled cormobity (DM, hypertension, infection) f) internal use of phenytoine, flucytosyne, or warfarin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate (RECIST criteria)
- Secondary Outcome Measures
Name Time Method Adverse events (NCI-CTC/AE version 3)